Business context and reporting period
TScan Therapeutics, Inc. filed this Form 8-K on September 30, 2026, reporting executive separation arrangements arising from a previously disclosed strategic reorganization. The filing does not report a financial-results period.
Financial and operating information
The filing provides no revenue, profit, cash flow, margin, debt, liquidity, or other operating metrics.
Executive departures and changes
- Jason A. Amello will cease serving as Chief Financial Officer, and Chrystal Louis, M.D., MPH, will cease serving as Chief Medical Officer, as previously disclosed in the September 2, 2026 Form 8-K.
- The company entered into separation agreements with Dr. Louis on September 24 and Mr. Amello on September 25, 2026. Each executive’s employment is scheduled to end on the earlier of November 1, 2026, or the date the executive begins other employment, consulting, or paid board service.
- Base salary and applicable employee benefits continue through each executive’s separation date.
Compensation, outlook, and contingencies
- Both executives remain entitled to previously disclosed termination-related payments and benefits; amounts are not specified in this filing.
- Under the November 2025 retention program, Mr. Amello may receive a conditional $85,000 lump-sum cash award and Dr. Louis a conditional $125,000 award. Each is payable only if a specified company milestone is achieved before that executive’s separation date.
- The filing provides no broader financial guidance or outlook. The separation agreements’ full text is to be filed as exhibits to the company’s Form 10-Q for the quarter ending September 30, 2026.
Important facts for investors to verify
- Review the forthcoming 10-Q exhibits for the full separation terms and the previously disclosed termination-related payments and benefits.
- Check whether the specified milestone is achieved before either separation date and whether the conditional retention awards become payable.
- Confirm the executives’ actual separation dates, which may be earlier than November 1, 2026.